profit from every SEK 100 of sales.
SEK 0SEK 100
AddLife
SEK 184.00-0.05% today
+4.4% in 1 year
1-year low SEK 134.601-year high SEK 190.60
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay SEK 40.04 for every SEK 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What AddLife sold, what it kept, and what it did with the cash.
Sales went from SEK 9.08 billion in 2022 to SEK 10.4 billion in 2025, with SEK 560 million of profit last year.
SalesProfit
AddLife handed back 8% of the cash it generated last year.
SEK 91M
Free cash flow 2025SEK 1.1B
Bought back its own shares–
Paid as dividendsSEK 91M
Cash vs. debtSEK 813M vs. SEK 4.8B
AddLife vs. similar companies
AddLife grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from SEK 100 of sales | Sales growth a year | Price per SEK 1 of profit |
|---|---|---|---|
| AddLife | 40.0× · Expensive | ||
 Intuitive Surgical | 55.9× · Expensive | ||
 EssilorLuxottica Société anonyme | 37.7× · Expensive | ||
 Becton, Dickinson and | 34.9× · Expensive | ||
 Medline | 46.2× · Expensive |
AI analysis
An AI analyst reads AddLife's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9,084 | 9,685 | 10,286 | 10,442 | |
| 3,427 | 3,599 | 3,859 | 3,977 | |
| 712 | 437 | 716 | 829 | |
| 1,437 | 1,534 | 1,517 | 1,783 | |
| 480 | 190 | 252 | 560 | |
| 3.95 | 1.56 | 2.06 | 4.59 | |
| 37.7% | 37.2% | 37.5% | 38.1% | |
| 7.8% | 4.5% | 7.0% | 7.9% | |
| 5.3% | 2.0% | 2.4% | 5.4% |
Balance sheet
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 13,057 | 12,745 | 13,055 | 12,711 |
| Cash | 376 | 272 | 331 | 813 |
| Total debt | 5,591 | 5,289 | 5,072 | 4,774 |
| Total liabilities | 8,086 | 7,785 | 7,746 | 7,264 |
| 4,968 | 4,958 | 5,306 | 5,443 | |
| 122 | 122 | 122 | 122 | |
| 5.4% | 4.8% | 5.4% | 7.6% | |
| 9.7% | 3.8% | 4.7% | 10.3% |
Cash flow
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 909 | 773 | 1,095 | 1,392 | |
| 282 | 308 | 297 | 284 | |
| 627 | 465 | 798 | 1,108 | |
| Dividends paid | 243 | 146 | 61 | 91 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 40.0×
- –
- 7.80
- 3.5×
- 2.1×
- 20.2×
- 14.8×
- 4.9%
- 2.5%
- 0.4%
Profitability
- 38.1%
- 7.9%
- 5.4%
- –
- 7.6%
- 5.8%
- –
- –
- –
- –
Growth
- +4.8%
- +5.1%
- –
- –
- −0.1%
Financial health
- 2.2×
- 0.88
- –
- 4.8×
- 1.04
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 39%of 948
Bottom 47%of 871
Bottom 32%of 560
Bottom 26%of 868
Top 21%of 985
0.4%of the share price, paid each year
On $1,000 invested$4a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
16.3% of its profit
Room to growStretchedMore than it earns: 8.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
30No pass
Philip Fisher
35No pass
Peter Lynch
19No pass
Joel Greenblatt
10No pass
Charlie Munger
24No pass
Terry Smith
29No pass
Questions about AddLife
Is AddLife a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the AddLife AI analysis
What does AddLife do?
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. It is in Medical Instruments & Supplies, based in Stockholm, Sweden, with 2,295 employees.
Does AddLife pay a dividend?
Yes. At today's price the dividend is 0.4% a year, about 16% of its yearly profit. In 2025 it paid out SEK 91.0 million in dividends.
Is AddLife stock halal?
Yes. AddLife passes our halal screen: its business is permitted and its debt is 21% of its market value, under the 30% limit. How we check
How has AddLife stock done over the past year?
Up 4.4% over the past twelve months, to SEK 184.00. It traded between SEK 134.60 and SEK 190.60 and is 3.5% below its high.
Who are AddLife's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with AddLife's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.